Merck Tbk PT

Merck Tbk PT EBIT per Share

The EBIT per Share of Merck Tbk PT (MERK.JK) as of Oct 17, 2026 is 715.25 IDR. In the previous year, EBIT per Share was 430.72 IDR — a change of 66.06% (higher).

EBIT per Share

715.25IDR

YoY

66.06%

Last updated:

EBIT per Share of Merck Tbk PT is 2025 715.25 IDR. EBIT per Share of Merck Tbk PT was 2024 430.72 IDR. It decreases by 66.06% higher compared to the previous year.

The Merck Tbk PT EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
105.20 IDR
Jan 1, 2019
280.35 IDR
Jan 1, 2020
242.26 IDR
Jan 1, 2021
427.51 IDR
Jan 1, 2022
533.65 IDR
Jan 1, 2023
445.82 IDR
Jan 1, 2024
430.72 IDR
Jan 1, 2025
715.25 IDR
The Merck Tbk PT EBIT per Share history
YEAREBIT per ShareYoY
715.25IDR+66.06%
430.72IDR-3.39%
445.82IDR-16.46%
533.65IDR+24.83%
427.51IDR+76.47%
242.26IDR-13.58%
280.35IDR+166.49%
105.20IDR-77.40%
465.39IDR-2.25%
476.11IDR+14.04%
417.50IDR-6.66%
447.29IDR-12.87%
513.34IDR+62.82%
315.29IDR-49.31%
621.94IDR+80.29%
344.97IDR-23.28%
449.67IDR+43.74%
312.84IDR+13.16%
276.46IDR+3.61%
266.82IDR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merck Tbk PT Stock analysis

What does Merck Tbk PT do? Merck Tbk PT is a pharmaceutical company based in Jakarta Timur, DKI Jakarta, operating within the Health Care sector. The company, listed on the Indonesian stock exchange with ticker MERK.JK and ISIN ID1000136609, has been publicly traded since its IPO on July 23, 1981. It employs 376 full-time staff and focuses on the development and distribution of pharmaceutical and chemical products. The company operates through three business segments: Biopharma, which covers ethical pharmaceutical products; Consumer Health, which includes over-the-counter products; and Others, which encompasses additional business activities. Merck Tbk PT is committed to providing personalized treatments for serious diseases and supports initiatives related to reproductive health, including enabling individuals to achieve their goal of becoming parents. The company's official website is https://www.merckgroup.com/id-id, where further information about its operations and services can be accessed. As a publicly listed entity, Merck Tbk PT is subject to regulatory disclosures and financial reporting requirements in Indonesia. The company's primary focus remains on delivering healthcare solutions through its pharmaceutical and chemical offerings, targeting both professional medical markets and consumer health needs. Merck Tbk PT is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck Tbk PT stock

EBIT per Share of Merck Tbk PT is 715.25 IDR in 2025.

EBIT per Share of Merck Tbk PT changed from 430.72 IDR to 715.25 IDR, representing a 66.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Merck Tbk PT since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Merck Tbk PT

All Key Metrics — Merck Tbk PT